Kaplan Fox Urges Smartsheet Inc. (NYSE: SMAR) Investors to Contact the Firm Before the Deadline on October 5, 2026

Kaplan Fox & Kilsheimer filed a proposed securities class action against Smartsheet on behalf of shareholders who sold stock between June 1 and September 23, 2024, with a lead-plaintiff deadline of October 5, 2026. The complaint alleges Smartsheet repurchased shares while allegedly withholding a formal acquisition offer from Blackstone and Vista Equity Partners at prices materially above the market and repurchase prices. The allegations create litigation and governance risk, though the release does not quantify claimed damages or establish liability.

Analysis

This is not a fundamental catalyst for BX. Any exposure from a pre-close disclosure/buyback claim would ordinarily sit with the acquired entity, be governed by transaction indemnities, insurance, or a negotiated reserve, rather than create a meaningful draw on Blackstone’s fee-related earnings or realizations. The filing is a plaintiff-firm solicitation, not an adjudication; absent a court ruling, settlement reserve, or evidence that the buyer assumed an uncapped liability, the appropriate expected-value impact is immaterial relative to BX’s diversified AUM base.

The relevant second-order issue is governance diligence for sponsor-led take-privates: a material settlement could marginally increase legal diligence costs and extend signing-to-close timetables for public-company transactions, but it would not change the strategic appeal of software take-privates. Watch for consolidated litigation, lead-plaintiff appointment after October 5, and any filing identifying damages methodology or buyer indemnification. A near-term negative tape reaction in BX attributable solely to this notice would be liquidity-driven rather than an earnings revision opportunity.

Contrarian view: the market often treats M&A-related securities suits as headline risk even when settlement economics are modest and paid years later. The more decision-relevant signal would be discovery that changes the factual record around board process or financing disclosures; that could affect future sponsor reputation and deal certainty, whereas the current allegation does not establish either outcome.

Key Decisions for Investors

• No new directional position in BX based on this release; require evidence of a disclosed reserve, adverse motion-to-dismiss ruling, or settlement estimate large enough to affect fee-related earnings before revising valuation.
• Use any lawsuit-driven BX underperformance versus KKR or APO over the next 1-5 trading days as a relative-value watch item, not an automatic long: enter long BX / short KKR or APO only if the spread exceeds 5% without a corresponding change in fundraising, realization, or credit data.
• Set a legal-event alert for the October 5 lead-plaintiff deadline and subsequent consolidated complaint; reassess only if allegations extend to transaction documents, sponsor conduct, or a quantified claim against the post-acquisition owner.
• Do not infer an investment implication for BAC or ALV from this item; neither has a clear economic transmission channel in the supplied information.